Plain-English translation of NCT06592274 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help people with moderate to severe plaque psoriasis — a condition where thick, red, scaly patches develop on the skin. Researchers want to find the best dose and treatment schedule by comparing three different ways of giving the medication. The goal is to learn whether this treatment works well and is safe for psoriasis patients.
Psoriasis can be difficult to treat, and many patients need better options that work effectively with fewer side effects. This medication targets a specific part of the immune system involved in psoriasis, and this trial will help doctors understand the best way to use this new treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive the medication at one of three different dose and schedule combinations. You will receive injections as part of your treatment plan and will have regular visits with the research team to check how well the medication is working and watch for any side effects. The study will track your psoriasis symptoms, take blood samples to check your body's immune response, and monitor your overall health throughout the trial period.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China